首页> 外文OA文献 >Derivation and validation of a novel prognostic scale (modified–stroke subtype, Oxfordshire community stroke project classification, age, and prestroke modified rankin) to predict early mortality in acute stroke
【2h】

Derivation and validation of a novel prognostic scale (modified–stroke subtype, Oxfordshire community stroke project classification, age, and prestroke modified rankin) to predict early mortality in acute stroke

机译:推导和验证新的预后量表(改良卒中亚型,牛津郡社区卒中项目分类,年龄和前卒中改良Rankin),以预测急性卒中的早期死亡率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and Purpose\ud—The stroke subtype, Oxfordshire Community Stroke Project classification, age, and prestroke modified Rankin (SOAR) score is a prognostic scale proposed for early mortality prediction after acute stroke. We aimed to evaluate whether including a measure of initial stroke severity (National Institutes of Health Stroke Scale and modified-SOAR [mSOAR] scores) would improve the prognostic accuracy.\ud\udMethods\ud—Using Anglia Stroke and Heart Clinical Network data, 2008 to 2011, we assessed the performance of SOAR and mSOAR against in-hospital mortality using area under the receiver operating curve statistics. We externally validated the prognostic utility of SOAR and mSOAR using an independent cohort data set from Glasgow. We described calibration using Hosmer–Lemeshow goodness-of-fit test.\ud\udResults\ud—A total of 1002 patients were included in the derivation cohort, and 105 (10.5%) died as inpatients. The area under the receiver operating curves for outcome of early mortality derived from the SOAR and mSOAR scores were 0.79 (95% confidence interval, 0.75–0.84) and 0.83 (95% confidence interval, 0.79–0.86), respectively (P=0.001). The external validation data set contained 1012 patients with stroke; of which, 121 (12.0%) patients died within 90 days. The mSOAR scores identified the risk of early mortality ranging from 3% to 42%. External validation of mSOAR score yielded an area under the receiver operating curve of 0.84 (95% confidence interval, 0.82–0.88) for outcome of early mortality. Calibration was good (P=0.70 for the Hosmer–Lemeshow test).\ud\udConclusions\ud—Adding National Institutes of Health Stroke Scale data to create a modified-SOAR score improved prognostic utility in both derivation and validation data sets. The mSOAR may have clinical utility by using easily available data to predict mortality.
机译:背景与目的卒中亚型,牛津郡社区卒中项目分类,年龄和卒中前改良兰金(SOAR)评分是建议用于急性卒中后早期死亡率预测的预后量表。我们旨在评估是否包括测量初始卒中严重程度(美国国立卫生研究院卒中量表和改良的SOAR [mSOAR]评分)是否会改善预后准确性。\ ud \ udMethods \ ud-使用Anglia卒中和心脏临床网络数据, 2008年至2011年,我们使用接收器工作曲线统计下的面积评估了SOAR和mSOAR对医院内死亡率的表现。我们使用来自格拉斯哥的独立队列数据集从外部验证了SOAR和mSOAR的预后功能。我们使用Hosmer-Lemeshow拟合优度检验描述了校准。\ ud \ udResults \ ud-派生队列中总共包括1002例患者,住院死亡105例(10.5%)。从SOAR和mSOAR评分得出的早期死亡结果的接收者操作曲线下面积分别为0.79(95%置信区间,0.75-0.84)和0.83(95%置信区间,0.79-0.86)(P = 0.001) 。外部验证数据集包含1012例中风患者。其中121例(12.0%)患者在90天内死亡。 mSOAR评分确定了3%至42%的早期死亡风险。外部验证mSOAR评分可得出早期死亡结果的受试者工作曲线下面积为0.84(95%置信区间为0.82-0.88)。校准良好(Hosmer–Lemeshow检验的P = 0.70)。\ ud \ ud结论\ ud-添加美国国立卫生研究院卒中量表数据来创建改良的SOAR评分,从而改善了推论和验证数据集中的预后效用。通过使用容易获得的数据来预测死亡率,mSOAR具有临床实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号